Anika Therapeutics reported $2.84M in Net Income for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 1793M 369M
Acorda Therapeutics ACOR:US $ -33.45M 49.6M
Adamas Pharmaceuticals ADMS:US -18273000 6.36M
Agenus AGEN:US $ -53.68M 16.07M
Agios Pharmaceuticals AGIO:US $ 1874.32M 1971.98M
Anika Therapeutics ANIK:US $ 2.84M 18.49M
Arrowhead Research ARWR:US $ -26818000 6.09M
Chemocentryx CCXI:US $ -29.71M 0.16M
Dicerna Pharmaceuticals DRNA:US $ -29.96M 6.62M
Enanta Pharmaceuticals ENTA:US $ -22.04M 13.72M
Halozyme Therapeutics HALO:US $ 73.16M 36.96M
Immunogen IMGN:US $ 31.39M 53.76M
Insmed INSM:US $ -91641000 10.57M
Integra Lifesciences IART:US $ 45.39M 47.35M
Johnson & Johnson JNJ:US $ 6197M 4459M
Karyopharm Therapeutics KPTI:US $ -57414000 13.99M
Ligand Pharmaceuticals LGND:US $ 18.11M 12.34M
Macrogenics MGNX:US $ -51.27M 49.18M
Merit Medical Systems MMSI:US $ 10.96M 4.42M
Rigel Pharmaceuticals RIGL:US $ 39.5M 58.74M
Sangamo Biosciences SGMO:US $ -45.93M 5.33M
Stryker SYK:US $ 302M 266M
Surmodics SRDX:US $ 8.09M 8.36M
Veracyte VCYT:US $ -8.04M 3.92M
Xencor XNCR:US $ -2.49M 11.2M